Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Prolymphocytic, T-Cell × INCB039110 × 1 year × Clear all

Sponsor

Conditions

Primary Myelofibrosis 2 Myeloproliferative Disorders 2 Thrombocytosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Neoplasm Metastasis 1 Myelodysplastic Syndromes 1 Lymphoma, Mantle-Cell 1 Lung Neoplasms 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Inhibition, Psychological 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Graft vs Host Disease 1 Carcinoma, Non-Small-Cell Lung 1 B-cell Malignancies 1 Anemia, Refractory, with Excess of Blasts 1

Interventions

ruxolitinib 3 venetoclax 2 duvelisib 2 thymoglobulin 1 romidepsin 1 itacitinib 1 fludarabine phosphate 1 fludarabine 1 Stem Cell Transplantation 1 Lisaftoclax 1 Depsipeptides 1 Cladribine 1 Busulfan 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡